News & Media

Press release
Medivir announces positive data from the phase II study of remetinostat in patients with early-stage cutaneous T-cell lymphoma

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces the completion of the phase II clinical study of the topical,...

Read more
Press release
New data on MIV-818 will be presented at EASL's International Liver Congress™ 2017

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that preclinical data on MIV-818 will be presented by Medivir at...

Read more
Press release
New data for simeprevir will be presented at EASL's International Liver Congress™ 2017

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today informs that new clinical data for simeprevir, an NS3/4A protease inhibitor for...

Read more
Press release
Annual Report 2016

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2016 now is available at the...

Read more
Press release
Notice of Annual General Meeting of Medivir AB (publ)

The shareholders in Medivir AB are hereby summoned to the annual general meeting on Wednesday 3 May 2017 at 2 p.m....

Read more
Press release
Number of shares and votes in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the number of shares and votes in Medivir has changed...

Read more
Press release
Medivir completes transition of commercial products to fully focus on research and development

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that it has come to agreement with Janssen to outlicense the...

Read more
Press release
Presentation of the result of Medivir’s voluntary redemption programme

Stockholm, Sweden – Medivir AB (Nasdaq Stockholm: MVIR) today announces the result of Medivir’s voluntary redemption programme. The redemption programme comprised...

Read more
Press release
Medivir’s Nomination Committee proposes new Board of Directors ahead of 2017 AGM

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced the Nomination Committee’s proposal for a new Board of Directors that...

Read more
Press release
Executive management team members increase their holdings in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that departing CEO, Niklas Prager, CEO designate Christine Lind and CFO...

Read more
Press release
MEDIVIR AB – FINANCIAL STATEMENT, JANUARY – DECEMBER 2016

Significant events during the fourth quarter Medivir focuses research and development operations exclusively on oncology and reorganises in order to achieve...

Read more
Press release
Christine Lind new CEO of Medivir AB effective 1 April 2017

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces today that Christine Lind has been appointed as the new CEO of...

Read more